| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| SCHEDULE 13G | Open Document | Open Filing | 10 Dec 2025 | |||
| 13F-HR | Open Document | Open Filing | 14 Nov 2025 | 30 Sep 2025 | 028-21006 | |
| SCHEDULE 13G/A | Open Document | Open Filing | 14 Nov 2025 | |||
| N-PX | Open Document | Open Filing | 02 Sep 2025 | 30 Jun 2025 | 028-21006 | |
| 13F-HR | Open Document | Open Filing | 14 Aug 2025 | 30 Jun 2025 | 028-21006 | |
| SCHEDULE 13G/A | Open Document | Open Filing | 15 May 2025 | |||
| 13F-HR | Open Document | Open Filing | 15 May 2025 | 31 Mar 2025 | 028-21006 | |
| 13F-HR | Open Document | Open Filing | 14 Feb 2025 | 31 Dec 2024 | 028-21006 | |
| SCHEDULE 13G/A | Open Document | Open Filing | 14 Feb 2025 | |||
| SC 13G/A | Open Document | Open Filing | TG THERAPEUTICS, INC | 14 Nov 2024 | ||
| 13F-HR | Open Document | Open Filing | 14 Nov 2024 | 30 Sep 2024 | 028-21006 | |
| SC 13G | Open Document | Open Filing | 03 Sep 2024 | |||
| 13F-HR | Open Document | Open Filing | 14 Aug 2024 | 30 Jun 2024 | 028-21006 | |
| N-PX | Open Document | Open Filing | 30 Jul 2024 | 30 Jun 2024 | 028-21006 | |
| 13F-HR | Open Document | Open Filing | 15 May 2024 | 31 Mar 2024 | 028-21006 | |
| 13F-HR | Open Document | Open Filing | 14 Feb 2024 | 31 Dec 2023 | 028-21006 | |
| SC 13G/A | Open Document | Open Filing | TG THERAPEUTICS, INC. | 14 Feb 2024 | ||
| 13F-HR | Open Document | Open Filing | 14 Nov 2023 | 30 Sep 2023 | 028-21006 | |
| 13F-HR | Open Document | Open Filing | 14 Aug 2023 | 30 Jun 2023 | 028-21006 | |
| 4 | Open Document | Open Filing | 28 Jun 2023 | 27 Jun 2023 | 001-40505 | |
| SC 13D/A | Open Document | Open Filing | AMBRX BIOPHARMA INC. | 28 Jun 2023 | ||
| SC 13D/A | Open Document | Open Filing | AMBRX BIOPHARMA INC. | 25 May 2023 | ||
| 13F-HR | Open Document | Open Filing | 15 May 2023 | 31 Mar 2023 | 028-21006 | |
| SC 13G | Open Document | Open Filing | TG THERAPEUTICS, INC. | 03 Apr 2023 | ||
| 4 | Open Document | Open Filing | 08 Mar 2023 | 27 Feb 2023 | 001-40505 | |
| 3 | Open Document | Open Filing | 08 Mar 2023 | 01 Jan 2023 | 001-40505 | |
| SC 13D | Open Document | Open Filing | AMBRX BIOPHARMA INC. | 08 Mar 2023 | ||
| 13F-HR | Open Document | Open Filing | 14 Feb 2023 | 31 Dec 2022 | 028-21006 | |
| SC 13G/A | Open Document | Open Filing | AMBRX BIOPHARMA INC. | 14 Feb 2023 | ||
| SC 13G | Open Document | Open Filing | 19 Dec 2022 | |||
| 13F-HR | Open Document | Open Filing | 14 Nov 2022 | 30 Sep 2022 | 028-21006 | |
| 13F-HR | Open Document | Open Filing | 15 Aug 2022 | 30 Jun 2022 | 028-21006 | |
| 13F-HR | Open Document | Open Filing | 16 May 2022 | 31 Mar 2022 | 028-21006 | |
| 13F-HR | Open Document | Open Filing | 14 Feb 2022 | 31 Dec 2021 | 028-21006 | |
| 13F-HR | Open Document | Open Filing | 15 Nov 2021 | 30 Sep 2021 | 028-21006 | |
| SC 14D9 | Open Document | Open Filing | ACCELERON PHARMA INC. | 20 Oct 2021 | ||
| 13F-HR | Open Document | Open Filing | 16 Aug 2021 | 30 Jun 2021 | 028-21006 | |
| 13F-HR | Open Document | Open Filing | 17 May 2021 | 31 Mar 2021 | 028-21006 | |
| 13F-HR | Open Document | Open Filing | 16 Feb 2021 | 31 Dec 2020 | 028-21006 |